Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • Nora AI
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Dignitana Q1'23 - Reaching the inflection point

Dignitana

Redeye’s view on Dignitana is generally unchanged. The sales momentum continued in the quarter with better cost control. The gross margin bounced back to the normal range after Q4. The US market is changing, and many positive signs exist. The turning to a positive EBITDA is positive, and together with solid 35% growth in the quarter, we see that the company has reached the inflection point. With the positive and negative estimate adjustments, we adjust our fair value range only at the high end to 23 (22) while maintaining our Base case value of SEK 12 (12) per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Dignitana Q1'23 - Reaching the inflection point

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.